Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis

Infection and Immunity

Volumn 65, Issue 10, 1997, Pages 4022-4029

  Vogel, Ulrich ^a   Weinberger, Andreas ^b,c   Frank, Ronald ^d   Müller, Astrid ^b   Köhl, Jörg ^b   Atkinson, John P ^c   Frosch, Matthias ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN A; MONOCLONAL ANTIBODY; SIALIC ACID DERIVATIVE;

ARTICLE; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIUM MUTANT; COMPLEMENT SYSTEM; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEROTYPE; STRAIN DIFFERENCE;

EID: 0030748949     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.10.4022-4029.1997     Document Type: Article

References (54)

1. Bishof, N. A., T. R. Welch, and L. S. Beischel. 1990. C4B deficiency: a risk factor for bacteremia with encapsulated organisms. J. Infect. Dis. 162:248-250.
2. Blaser, M. J., P. F. Smith, J. E. Repine, and K. A. Joiner. 1988. Pathogenesis of Campylobacter fetus infections. J. Clin. Invest. 81:1434-1444.
3. Bloom, H., H. Beier, and H. S. Gross. 1987. Improved silver staining of plant proteins. RNA and DNA in polyacrylamide gels. Electrophoresis 8:93-99.
4. Brandtzaeg, P., K. Høgåsen, P. Kierulf, and T. E. Mollnes. 1996. The extensive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J. Infect. Dis. 173: 647-655.
5. Campbell, J. R., C. J. Baker, and M. S. Edwards. 1991. Deposition and degradation of C3 on type III group B streptococci. Infect. Immun. 59:1978-1983.
6. Cartwright, K. 1995. Meningococcal carriage and disease, p. 115-146. In K. Cartwright (ed.), Meningococcal disease. John Wiley and Sons Ltd., Chichester, England.
7. Croize, J., J. Arvieux, P. Berche, and M. G. Colomb. 1993. Activation of the human complement alternative pathway by Listeria monocytogenes: evidence for direct binding and proteolysis of the C3 component on bacteria. Infect. Immun. 61:5134-5139.
8. de la Paz, H., S. J. Cook, and J. E. Heckels. 1995. Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer membrane antigens. Microbiology 141:913-920.
9. Elkins, C., N. H. Carbonetti, V. A. Varela, D. Stirewalt, D. G. Klapper, and P. F. Sparling. 1992. Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipooligosaccharide is not sialylated. Mol. Microbiol. 6:2617-2628.
10. Figueroa, J., J. Andreoni, and P. Densen. 1993. Complement deficiency states and meningococcal disease. Immunol. Res. 12:295-311.
11. Fitzgerald, T. J. 1987. Activation of the classical and alternative pathways of complement by Treponema pallidum subsp. pallidum and Treponema vincentii. Infect. Immun. 55:2066-2073.
12. Frank, R. 1992. Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48:9217-9232.
13. Frank, R., and H. Overwin. 1996. Spot synthesis: epitope analysis with arrays of synthetic peptides prepared on cellulose membranes, p. 149-169. In G. E. Morris (ed.), Epitope mapping protocols. Humana Press Inc., Totowa, N.J.
14. Frosch, M., C. Weisgerber, and T. Meyer. 1989. Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc. Natl. Acad. Sci. USA 86:1669-1673.
15. Gill, M. J., D. P. McQuillen, J. P. M. van Putten, L. M. Wetzler, J. Bramley, H. Crooke, N. J. Parsons, J. A. Cole, and H. Smith. 1996. Functional characterization of a sialyl-transferase-deficient mutant of Neisseria gonorrhoeae. Infect. Immun. 64:3374-3378.
16. Gordon, D. L., J. Rice, J. J. Finlay-Jones, P. J. McDonald, and M. K. Hostetter. 1988. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization. J. Infect. Dis. 157:697-704.
17. Hamadeh, R. M., M. M. Estabrook, P. Zhou, G. A. Jarvis, and J. M. Griffis. 1995. Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing. Infect. Immun. 63:4900-4906.
18. Hammerschmidt, S., C. Birkholz, U. Zähringer, B. D. Robertson, J. P. M. van Putten, O. Ebeling, and M. Frosch. 1994. Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol. Microbiol. 11:885-896.
19. Hammerschmidt, S., R. Hilse, J. P. M. van Putten, R. Gerardy-Schahn, A. Unkmeir, and M. Frosch. 1996. Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J. 15:192-198.
20. Horstmann, R. D. 1492. Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation. Infect. Immun. 60:721-727.
21. Jarvis, G. A., and N. A. Vedros. 1987. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect. Immun. 55:174-180.
22. Jarvis, G. A., and J. M. Griffis. 1989. Human IgA initiates complement-mediated killing of Neisseria meningitidis. J. Immunol. 143:1703-1709.
23. Jarvis, G. A. 1994. Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoea. Infect. Immun. 62:1755-1750.
24. Jarvis, G. A. 1995. Recognition and control of neisserial infection by antibody and complement. Trends Microbiol. 3:198-201.
25. Joiner, K. A., K. A. Warren, E. J. Brown, J. Swanson, and M. M. Frank. 1983. Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae. J. Immunol. 131:1143-1151.
26. Joiner, K. A., K. A. Warren, C. Hammer, and M. M. Frank. 1985. Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae. J. Immunol. 134:1920-1925.
27. Joiner, K. A. 1988. Complement evasion by bacteria and parasites. Annu. Rev. Microbiol. 42:201-230.
28. Jones, D. 1995. Epidemiology of meningococcal disease in Europe and the USA, p. 147-157. In K. Cartwright (ed.), Meningococcal disease. John Wiley and Sons Ltd., Chichester, England.
29. Kim, J. J., D. Zhou, R. E. Mandrell, and J. M. Griffiss. 1992. Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis. Infect. Immun. 60:4439-4442.
30. Klein, N. J., C. A. Ison, M. Peakman, M. Levin, S. Hammerschmidt, M. Frosch, and R. S. Heyderman. 1996. The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J. Infect. Dis. 173:172-179.
31. Klos, A., V. Ihrig, M. Messner, J. Grabbe, and D. Bitter-Suermann. 1988. Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies. J. Immunol. Methods 111:241-252.
32. Kozel, T. R. 1996. Activation of the complement system by pathogenic fungi. Clin. Microbiol. Rev. 9:34-46.
33. Lee, F. K. N., D. S. Stephens, B. W. Gibson, J. J. Engstrom, D. Zhou, and M. A. Apicella. 1995. Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB. Infect. Immun. 63:2508-2515.
34. Levy, N. J., and D. L. Kasper. 1986. Surface-bound capsular polysaccharide of type 1a group B Streptococcus mediates C1 binding and activation of the classical complement pathway. J. Immunol. 136:4157-4162.
35. Mandrell, R. E., and M. A. Apicella. 1993. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modifications of LOS. Immunobiology 187:382-402.
36. Mandrell, R. E., J. J. Kim, C. M. John, B. W. Gibson, J. V. Sugai, M. A. Apicella, J. M. Griffiss, and R. Yamasaki. 1991. Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis. J. Bacteriol. 173:2823-2832.
37. Marques, M. B., D. L. Kasper, M. K. Pangburn, and M. R. Wessels. 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60:3986-3993.
38. Masson, L., and B. E. Holbein. 1985. Influence of nutrient limitation and low pH on serogroup B Neisseria meningitidis capsular polysaccharide levels: correlation with virulence for mice. Infect. Immun. 47:465-471.
39. Masson, L., B. E. Holbein, and F. E. Ashton. 1982. Virulence linked to polysaccharide production in serogroup B Neisseria meningitidis. FEMS Microbiol. Lett. 13:187-190.
40. Moran, E. E., B. L. Brandt, and W. D. Zollinger. 1994. Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity. Infect. Immun. 62:5290-5295.
41. Parsons, N. J., J. R. C. Andrade, P. V. Patel, J. A. Cole, and H. Smith. 1989. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5′-monophospho-N-acetyl neuraminic acid. Microb. Pathog. 7:63-72.
42. Platonov, A. E., V. B. Beloborodov, L. I. Pavlova, I. V. Vershinina, and H. Kayhty. 1995. Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine. Clin. Exp. Immunol. 100:32-39.
43. Pluschke, G., J. Mayden, M. Achtman, and R. P. Levine. 1983. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing. Infect. Immun. 42:907-913.
44. Pluschke, G., and M. Achtman. 1984. Degree of antibody-independent activation of the classical pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns. Infect. Immun. 43:684-692.
45. Reinhard, P. 1993. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae. Immunology 79:638-652.
46. Rest, R. F., and J. V. Frangipane. 1992. Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils. Infect. Immun. 60:989-997.
47. Robertson, B. D., M. Frosch, and J. P. M. van Putten. 1993. The role of galE in the biosynthesis and function of gonococcal lipopolysaccharide. Mol. Microbiol. 8:891-901.
48. Ross, S. C., P. J. Rosenthal, H. M. Berberich, and P. Densen. 1987. Killing of Neisseria meningitidis by human neutrophils: implication for normal and complement deficient individuals. J. Infect. Dis. 155:1266-1275.
49. Smith, H., N. J. Parsons, and J. A. Cole. 1995. Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity. Microb. Pathog. 19:365-377.
50. Stimson, E., M. Virji, K. Makepiece, A. Dell, H. R. Morris, G. Payne, J. R. Saunders, M. P. Jennings, S. Barker, M. Panico, I. Blench, and E. R. Moxon. 1995. Meningococcal pilin: a glycoprotein substituted with digalactosyl 2,4-diacetamido-2,4,6-trideoxyhexose. Mol. Microbiol. 17:1201-1214.
51. van Emmerik, L. C., E. J. Kuijper, C. A. P. Fijen, J. Dankert, and S. Thiel. 1994. Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin. Exp. Immunol. 97:411-416.
52. Vogel, U., S. Hammerschmidt, and M. Frosch. 1996. Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitidis sero-group B are prerequisites for virulence of meningococci in the infant rat. Med. Microbiol. Immunol. 185:81-87.
53. Weiler, J. M. 1993. Introduction, p. 8-37. In K. Whaley, M. Loos, and J. M. Weiler (ed.), Complement in health and disease, 2nd ed. Kluwer Academic Publishers, Dordrecht, The Netherlands.
54. Wetzler, L. M., K. Barry, M. S. Blake, and E. C. Gotschlich. 1992. Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera. Infect. Immun. 60:339-343.